Home Insight Page 12

Top Stories in Insight

Here we go again

Every five or so years, someone pitches the idea that Halifax needs a professional sports team

A chance to prove your worth

Editorial

  • February 15, 2018 November 17, 2019
  • 00:02

Trudeau’s cockiness on NAFTA

Would the Americans be willing to ease up on their NAFTA demands if Canada were to back off on its WTO complaint?

Balancing revolution and risk

Editorial

  • February 5, 2018 November 12, 2019
  • 00:02

On ethics and suit lapels

Trudeau, sanctioned over his 2016 vacation, was hardly the first prime minister to run afoul of ethical standards

Now is the time for major improvements

Editorial

  • By: IE Staff
  • January 15, 2018 November 12, 2019
  • 00:01

Don’t write off NAFTA yet

Finding enough support in Congress to eliminate a program that has benefited significant numbers of Americans is next to impossible

The art of doing nothing

Editorial

  • By: IE Staff
  • December 22, 2017 November 12, 2019
  • 00:40

Technology, regulation and competition

Editorial

  • By: IE Staff
  • December 1, 2017 November 12, 2019
  • 00:30

A woeful record on diversity

Editorial

  • By: IE Staff
  • November 14, 2017 November 12, 2019
  • 00:40

Best fight against big data is “best interest’

Editorial

  • By: IE Staff
  • October 27, 2017 November 12, 2019
  • 00:30

Embedded fees: A comparison

Editorial

  • By: IE Staff
  • October 13, 2017 November 12, 2019
  • 00:30

Finding the will to make change happen

Editorial

  • By: IE Staff
  • September 21, 2017 November 12, 2019
  • 23:40

Bare trust debacle makes fools of the law-abiding

Editorial: Last-minute policy reversals undermine an already fragile trust between tax authorities and the public

  • By: IE Staff
  • March 29, 2024 March 29, 2024
  • 12:38

Guardian Capital acquires majority of Ontario investment counselling firm

CEO Ken Rae sells his stake but stays on as key leader

Pharmacare a promise Trudeau might come to regret

The Liberals’ re-election prospects look promising thanks to the co-operation of Big Pharma

What investors can expect in 2025

Uncertain policy backdrop, divergence among central banks and risk of re-emerging inflation are forecast to shape the investing landscape

Help your client sell their beneficial interest in an estate

Here’s your helpful guide to advising clients on a complex estate sales process

It’s time to re-evaluate U.S. equities allocation

High valuations and market concentration are headwinds for future returns

Letter: A déjà vu moment for bank sales practices

New review must be approached with urgency, transparency and a commitment to meaningful action, writes Harvey Naglie

Letter: OSC’s proposed disgorgement provisions are unfair and inadequate

A better solution is to start a compensation fund, writes lawyer Joseph Groia 

Letter: A case for rethinking investor education

Behavioural design is no silver bullet, writes Harvey Naglie